JPWO2020262603A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020262603A5
JPWO2020262603A5 JP2021527768A JP2021527768A JPWO2020262603A5 JP WO2020262603 A5 JPWO2020262603 A5 JP WO2020262603A5 JP 2021527768 A JP2021527768 A JP 2021527768A JP 2021527768 A JP2021527768 A JP 2021527768A JP WO2020262603 A5 JPWO2020262603 A5 JP WO2020262603A5
Authority
JP
Japan
Prior art keywords
amino
group
phenyl
trifluoromethyl
cyclopropanecarboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021527768A
Other languages
English (en)
Japanese (ja)
Other versions
JP7647552B2 (ja
JPWO2020262603A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/025187 external-priority patent/WO2020262603A1/ja
Publication of JPWO2020262603A1 publication Critical patent/JPWO2020262603A1/ja
Publication of JPWO2020262603A5 publication Critical patent/JPWO2020262603A5/ja
Application granted granted Critical
Publication of JP7647552B2 publication Critical patent/JP7647552B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021527768A 2019-06-28 2020-06-26 Ep2アンタゴニスト Active JP7647552B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019122077 2019-06-28
JP2019122077 2019-06-28
PCT/JP2020/025187 WO2020262603A1 (ja) 2019-06-28 2020-06-26 Ep2アンタゴニスト

Publications (3)

Publication Number Publication Date
JPWO2020262603A1 JPWO2020262603A1 (https=) 2020-12-30
JPWO2020262603A5 true JPWO2020262603A5 (https=) 2023-06-27
JP7647552B2 JP7647552B2 (ja) 2025-03-18

Family

ID=74060242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527768A Active JP7647552B2 (ja) 2019-06-28 2020-06-26 Ep2アンタゴニスト

Country Status (14)

Country Link
US (1) US20220388955A1 (https=)
EP (1) EP3992176B1 (https=)
JP (1) JP7647552B2 (https=)
KR (1) KR20220030219A (https=)
CN (1) CN114026068A (https=)
AU (1) AU2020306387A1 (https=)
BR (1) BR112021026397A2 (https=)
CA (1) CA3144201A1 (https=)
ES (1) ES3048491T3 (https=)
IL (1) IL289252A (https=)
MX (1) MX2021015654A (https=)
PH (1) PH12021553155A1 (https=)
TW (1) TW202114985A (https=)
WO (1) WO2020262603A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022138792A1 (https=) * 2020-12-24 2022-06-30
JP2024016314A (ja) * 2020-12-24 2024-02-07 小野薬品工業株式会社 一般式(i-a)で示される化合物、その薬学的に許容される塩、またはそれらの水和物と免疫チェックポイント阻害薬および/またはep4受容体拮抗薬との組み合わせ
JP2024016311A (ja) * 2020-12-24 2024-02-07 小野薬品工業株式会社 Ep2アンタゴニスト
WO2022272062A1 (en) 2021-06-24 2022-12-29 Reservoir Neuroscience, Inc. Ep2 antagonist compounds
US20250092008A1 (en) 2021-08-10 2025-03-20 Ono Pharmaceutical Co., Ltd. Process for making an ep4 antagonist
CN115417772B (zh) * 2022-09-26 2024-07-19 无锡双启科技有限公司 一种3-硝基-4-氟苯甲醚的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618702A (en) 1985-01-24 1986-10-21 E. I. Du Pont De Nemours And Company Manufacture of butanedicarboxylic acid esters
WO1986005779A1 (en) 1985-04-03 1986-10-09 Yamanouchi Pharmaceutical Co., Ltd. Phenylene derivatives
CN1313439C (zh) * 1998-08-07 2007-05-02 艾米斯菲尔技术有限公司 用于送递活性剂的化合物和组合物
ES2298168T3 (es) * 1999-12-16 2008-05-16 Emisphere Technologies, Inc. Compuestos y composiciones para suministrar agentes activos.
DK1666473T3 (da) * 2003-09-17 2013-03-25 Ono Pharmaceutical Co Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
JP2007516982A (ja) * 2003-12-15 2007-06-28 日本たばこ産業株式会社 シクロプロパン化合物及びその医薬用途
WO2005080367A1 (en) * 2004-02-12 2005-09-01 Pharmagene Laboratories Limited Ep2 receptor agonists
WO2006007448A2 (en) 2004-06-17 2006-01-19 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions and related methods of use
WO2007052843A1 (ja) 2005-11-04 2007-05-10 Takeda Pharmaceutical Company Limited 複素環アミド化合物およびその用途
KR20070052843A (ko) 2005-11-18 2007-05-23 로열 플래닛 캄퍼니 리미티드 가상현실 쇼핑 시스템
JP2008152097A (ja) 2006-12-19 2008-07-03 Nikon Corp 連続撮影制御方法および撮像装置
EP2003118A1 (de) 2007-06-13 2008-12-17 Bayer Schering Pharma Aktiengesellschaft Zimtsäurederivate als Modulatoren des EP2-Rezeptors
TWI410410B (zh) * 2007-08-10 2013-10-01 Ono Pharmaceutical Co Phenylacetic acid compounds
JP2012177618A (ja) 2011-02-25 2012-09-13 Nsk Ltd レゾルバ装置
WO2012177618A1 (en) 2011-06-20 2012-12-27 Emory University Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
WO2013164326A1 (en) * 2012-05-03 2013-11-07 Takeda Gmbh Novel ep2 receptor agonists

Similar Documents

Publication Publication Date Title
JPWO2020262603A5 (https=)
CN114984003B (zh) 芳族磺酰胺衍生物
TWI770113B (zh) 2-雜芳基-3-氧代-2,3-二氫噠嗪-4-甲醯胺
JP6505956B2 (ja) JAK阻害剤としてのピラゾロ[1,5−a]ピラジン−4−イル誘導体
US20240158372A1 (en) Bisamide sarcomere activating compounds and uses thereof
JP7611278B2 (ja) 金属酵素阻害剤化合物
KR101050974B1 (ko) 성장 호르몬 분비촉진 수용체의 그렐린 유사 리간드로서의신규한 트리아졸 유도체
JP2011500806A5 (https=)
CN106029064B (zh) 治疗化合物和组合物
JP6688735B2 (ja) mIDH1阻害剤としてのベンズイミダゾール−2−アミン
JP2020510668A (ja) Cftr増強物質としてのピロロピリミジン
JP2006316054A (ja) 高コンダクタンス型カルシウム感受性kチャネル開口薬
EA032609B1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
MX2010013555A (es) Agonistas del receptor de esfingosin 1-fosfato 1 y uso de los mismos.
FR2850652A1 (fr) Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
CN103384661A (zh) 盐皮质激素受体拮抗剂
JP2021535134A5 (https=)
JP2016534143A5 (https=)
RU2019117556A (ru) Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2
JP2021535137A5 (https=)
JP2020502058A5 (https=)
KR20060128950A (ko) 아미도피라졸 유도체
WO2017090743A1 (ja) 新規イミダゾール化合物およびメラノコルチン受容体作動薬としての用途
CN115461338A (zh) 具有kdm5抑制活性的3-氮杂二环(3.1.0)己烷衍生物及其用途
JP7416757B2 (ja) 置換テトラヒドロシクロペンタ[c]ピロール、置換ジヒドロピロリジン、その類似体、およびそれらを使用する方法